Maxillary osteonecrosis linked to Pembrolizumab therapy: a case report

Maxillary osteonecrosis linked to Pembrolizumab therapy: a case report

Introduction: Osteonecrosis of the jaw is a serious condition often associated with the use of bone-modifying agents or antiangiogenics. Recent evidence suggests that immune checkpoint inhibitors, including Pembrolizumab, might also contribute to osteonecrosis of the jaw. Observation: An 83-year-old...

Full description

Saved in:
Bibliographic Details
Main Authors: Gosselin-Rousselle Louise, Gaudimier Zoé, Pamelard Pierre-Olivier, Sader Paul, Moizan Hervé
Format: Article
Language:English
Published: EDP Sciences 2024-01-01
Series:Journal of Oral Medicine and Oral Surgery
Subjects:
pembrolizumab
osteonecrosis
maxilla
Online Access:https://www.jomos.org/articles/mbcb/full_html/2024/03/mbcb240188/mbcb240188.html
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items